摘要
目的评价养血清脑颗粒治疗椎-基底动脉供血不足的临床疗效。方法治疗组52例采用养血清脑颗粒治疗,对照组47例采用复方丹参片治疗。60d后分别观察两组患者临床疗效和血液流变学改善情况。结果总有效率养血清脑颗粒治疗组为88.5%(46/52例),复方丹参片对照组为68.1%(32/47例),差异有显著性意义(P<0.05);治疗组治疗后血液流变学3项指标改善明显优于对照组(P<0.05)。结论养血清脑颗粒治疗椎-基底动脉供血不足的疗效优于复方丹参片,是治疗椎-基底动脉供血不足的理想药物。
Objective To evaluate the clinical therapeutic effect of Yangxueqingnaokeli on treating vertebro-basilar artery insufficiency. Methods In therapeutic group（ n = 52 ）, patients were supplied Yangxueqingnaokeli and in control group（ n = 37）supplied FufangDanshen Tablet. After 60 days,the clinical effects and the change of bemorheology were observed index respectively. Results The total effective rate in therapeutic group was 88.5% （46/52 cases）and in control group was 68.1% （32/47 cases）. Compared with control group, there was obvious change of hemorheology indexes intherapeutic group （ P 〈 0.05 ）. Conclusion Therapeutic effect of Yangxueqingnaokeli is better than that of FufangDanshen Tablet in treating vertebro-basilar insufficiency.
出处
《中风与神经疾病杂志》
CAS
CSCD
北大核心
2009年第1期91-93,共3页
Journal of Apoplexy and Nervous Diseases
